Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03673007 · ClinicalTrials.gov registry record · NA

Michigan Contraceptive Access, Research, and Evaluation Study: Phase 1

A NA study of Pregnancy, sponsored by University of Michigan.

Active
Registry status
NA
Development phase
4,633
Enrollment target
9
Study locations

NCT03673007: Active NA study of Pregnancy, sponsored by University of Michigan.

NCT03673007 is a NA study of Pregnancy that is active but no longer recruiting, run by University of Michigan. The registered enrollment target is 4,633 participants, above the 848-participant average among 191 other Pregnancy trials with a reported enrollment target (446% higher). The trial reports 9 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03673007, a NA study of Pregnancy, is active but no longer recruiting, sponsored by University of Michigan.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
4,633 participants
Enrollment target
9
Study locations

Study Summary

M-CARES will use large-scale administrative data complemented by follow-up surveys and a randomized control trial (RCT) to estimate the causal impact of greater financial access to contraception on a comprehensive set of outcomes. Outcomes include contraceptive use, pregnancy, childbearing, and parenting strategies; partnership decisions and relationship quality; health and health care use; education, labor market success, and public assistance receipt; financial security; neighborhood quality; mental health and stress; and life plans. The resulting estimates will inform a more complete understanding of the costs and benefits of financial access to contraception and, therefore, the investment value of related policies and programs.

Primary Outcome

Share of participants that purchase contraception as determined by Planned Parenthood of Michigan (PPMI) billing records and code the outcome based on purchases of contraceptives within 100 days of study enrollment (0 for no use of contraception; 1 for use of contraception).

Conditions Studied

Interventions

  • BEHAVIORAL Gift card to be used for contraceptives that is valued at 50% of cost of name-brand IUD (August 26, 2018-March 3, 2019)
  • BEHAVIORAL Gift card to be used for contraceptives that is valued at 100% of cost of name-brand IUD (March 4, 2019-March 31, 2023)

Study Locations (9)

Michigan

  • Planned Parenthood - Ann Arbor-West - Ann Arbor
  • Planned Parenthood - Detroit - Detroit
  • Planned Parenthood - Ferndale - Ferndale
  • Planned Parenthood - Grand Rapids - Grand Rapids
  • Planned Parenthood - Kalamazoo - Kalamazoo
  • Planned Parenthood - Lansing - Lansing
  • Planned Parenthood - Livonia - Livonia
  • Planned Parenthood - Traverse City - Traverse City
  • Planned Parenthood - Warren - Warren

Trial Details

FieldValue
Enrollment Target 4,633 participants
Start Date 2018-08-26
Est. Completion 2028-12-31
Phase NA
University of Michigan

1,327 total trials

What the registry record for NCT03673007 still lists

NCT03673007 is an interventional study that assigns participants to a tested intervention. Its 4,633 participants enrollment target places it among the larger protocols in the corpus, above the 848-participant average among 191 other Pregnancy trials with a reported enrollment target (446% higher).

The record links to 1 condition, with Pregnancy appearing as the primary indexed condition, and to 2 interventions - of which Gift card to be used for contraceptives that is valued at 50% of cost of name-brand IUD (August 26, 2018-March 3, 2019) is the first listed.

NCT03673007 lists 9 locations in 1 state (Michigan).

Frequently Asked Questions

What is clinical trial NCT03673007 about?

NCT03673007 is a clinical study titled "Michigan Contraceptive Access, Research, and Evaluation Study: Phase 1". M-CARES will use large-scale administrative data complemented by follow-up surveys and a randomized control trial (RCT) to estimate the causal impact of greater financial access to contraception on a comprehensive set of outcomes. Outcomes include contraceptive use, pregnancy, childbearing, and pare...

What is the current status of trial NCT03673007?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 4,633 participants. The study started on 2018-08-26. Estimated completion is 2028-12-31.

What conditions does trial NCT03673007 study?

This clinical trial studies the following conditions: Pregnancy.

What interventions are being tested in trial NCT03673007?

The interventions under investigation include: Gift card to be used for contraceptives that is valued at 50% of cost of name-brand IUD (August 26, 2018-March 3, 2019) (BEHAVIORAL), Gift card to be used for contraceptives that is valued at 100% of cost of name-brand IUD (March 4, 2019-March 31, 2023) (BEHAVIORAL).

Who is sponsoring clinical trial NCT03673007?

This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03673007 being conducted?

This trial has 9 study locations across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pregnancy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03673007's enrollment target sits among peer trials

4,633 8th of 191 higher than 184 of 191 other Pregnancy trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Pregnancy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT06535139 · 4,630 participants · NA

    ReMARK: Addressing Disparities in Rural HPV-related Cancer Prevention

  • NCT05768217 · 4,600 participants · NA

    Community Resiliency Collective Efficacy Intervention

  • NCT05486572 · 4,700 participants · NA

    Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI

  • NCT06888388 · 4,700 participants

    Long-term Safety of Nipple Sparing Mastectomy in Women With High Penetrance Breast Cancer Susceptibility Genes in Breast Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03673007, the US trial registry maintained by the National Library of Medicine. NCT03673007 (large enrollment · multi site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.